TickerFacts.

Gyre Therapeutics, Inc. (GYRE): Shares Outstanding

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2022-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

91.31M
As of 2025-12-31
106.03M
As of 2026-06-30
+12.8%
3-year compound annual growth
2010-12-31: 28.87M2011-12-31: 33.38M2012-12-31: 33.62M2013-12-31: 33.72M2014-12-31: 370.9K2015-12-31: 762.0K2016-12-31: 801.8K2017-12-31: 6.08M2018-12-31: 11.95M2019-12-31: 12.04M2020-12-31: 22.10M2021-12-31: 31.41M2022-12-31: 63.59M2023-12-31: 76.60M2024-12-31: 86.31M2025-12-31: 91.31M91.31M
2010-12-31 Shares Outstanding (shares) 2025-12-31
Period endedShares OutstandingChange YoYSource filing
2025-12-3191.31M+5.8%2026-03-13, Balance as of period end
2024-12-3186.31M+12.7%2026-03-13, Balance as of period end
2023-12-3176.60M+20.5%2025-03-17, Balance as of period end
2022-12-3163.59Mn/c2024-03-27, Balance as of period end
2021-12-3131.41M+42.1%2023-03-30, Balance as of period end
2020-12-3122.10M+83.5%2022-03-31, Balance as of period end
2019-12-3112.04M+0.7%2021-03-04, Balance as of period end
2018-12-3111.95Mn/c2020-02-20, Balance as of period end
2017-12-316.08M+658.5%2019-03-08, Balance as of period end
2016-12-31801.8K+5.2%2018-03-19, Balance as of period end
2015-12-31762.0Kn/c2017-03-08, Balance as of period end
2014-12-31370.9K-98.9%2016-03-09, Balance as of period end
2013-12-3133.72M+0.3%2015-03-16, Balance as of period end
2012-12-3133.62M+0.7%2014-03-14, Balance as of period end
2011-12-3133.38M+15.6%2013-03-15, Balance as of period end
2010-12-3128.87Mn/a2012-03-06, Balance as of period end